# Efficacy and Safety of Integra Accell Evo3 DBM in Instrumented Lumbar Spine Fusion

> **NCT01714804** · NA · COMPLETED · sponsor: **SeaSpine, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Stenosis
- Spondylosis
- Degenerative Changes

## Interventions

- **DEVICE:** Accell Evo3 Prospective Use

## Key facts

- **NCT ID:** NCT01714804
- **Lead sponsor:** SeaSpine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01714804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01714804, "Efficacy and Safety of Integra Accell Evo3 DBM in Instrumented Lumbar Spine Fusion". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01714804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*